2,564 followers
WES was performed on 180 patients with early-onset epilepsy of unknown cause. A molecular diagnoses (pathogenic/likely pathogenic variants) was achieved in 59/180 patients (33%). Clinical management changed following WES findings in 13% of all patients htt